Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Bolt Biotherapeutics (BOLT) stocks in Canada
Learn how to easily invest in Bolt Biotherapeutics stocks.
Bolt Biotherapeutics is a biotechnology business based in the US. Bolt Biotherapeutics stocks (BOLT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $14.55 – a decrease of 10.47% over the previous week. Bolt Biotherapeutics employs 65 staff and has a trailing 12-month revenue of around $752,000.
How to buy shares in Bolt Biotherapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BOLT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Bolt Biotherapeutics stock price (NASDAQ:BOLT)Use our graph to track the performance of BOLT stocks over time.
Bolt Biotherapeutics shares at a glance
|Latest market close||$3.25|
|52-week range||$3.34 - $43.07|
|50-day moving average||$6.06|
|200-day moving average||$13.54|
|Wall St. target price||$22.20|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.20|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Bolt Biotherapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Bolt Biotherapeutics price performance over time
|1 week (2022-01-19)||-18.75%|
|1 month (2021-12-25)||N/A|
|3 months (2021-10-29)||-75.17%|
|6 months (2021-07-29)||-72.60%|
|1 year (2021-01-25)||N/A|
|2 years (2020-01-25)||N/A|
|3 years (2019-01-25)||N/A|
|5 years (2017-01-25)||N/A|
Bolt Biotherapeutics financials
|Gross profit TTM||$-40,126,000|
|Return on assets TTM||-26.13%|
|Return on equity TTM||-64.71%|
|Market capitalisation||$135.3 million|
TTM: trailing 12 months
Bolt Biotherapeutics share dividends
We're not expecting Bolt Biotherapeutics to pay a dividend over the next 12 months.
Bolt Biotherapeutics overview
Bolt Biotherapeutics, Inc. , a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; and BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015.
Stocks similar to Bolt Biotherapeutics
Bolt Biotherapeutics in the news
Appeals court upholds California's right to enforce its net neutrality law while the FCC remains at a standstill
Ackman takes a big stake in Netflix, excited about company's long-term prospects
7 Little-Known Penny Stocks That Could Take Off Any Moment
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Silver Spike Investment Corp. (SSIC) stock in Canada when it goes public
Everything we know about the Silver Spike Investment Corp. IPO, plus information on how to buy in.
How to buy MOD Pizza stock in Canada when it goes public
Everything we know about the MOD Pizza IPO, plus information on how to buy in.
How to buy Modular Medical (MODD) stock in Canada when it goes public
Everything we know about the Modular Medical IPO, plus information on how to buy in.
How to buy Direct Digital Holdings (DRCT) stock in Canada when it goes public
Everything we know about the Direct Digital Holdings IPO, plus information on how to buy in.
How to buy TC BioPharm (TCBP) stock in Canada when it goes public
Everything we know about the TC BioPharm IPO, plus information on how to buy in.
How to buy Maris-Tech Ltd (MTEK) stock in Canada when it goes public
Everything we know about the Maris-Tech Ltd IPO, plus information on how to buy in.
How to buy Phoenix Motor (PEV) stock in Canada when it goes public
Everything we know about the Phoenix Motor IPO, plus information on how to buy in.
How to buy Nauticus Robotics, Inc. (KITT) stock in Canada when it goes public
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.